These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3843366)

  • 1. [The HLA antigen system and the immune response in measles vaccination].
    Kharit SM; Kapralova MA
    Tr Inst Im Pastera; 1985; 62():72-5. PubMed ID: 3843366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 3. [The strength of postvaccinal measles immunity in schoolchildren].
    Smorodinova IP; Miroshnikova NK; Sobolevskaia AA
    Tr Inst Im Pastera; 1985; 62():46-50. PubMed ID: 2954275
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination.
    Ovsyannikova IG; Jacobson RM; Vierkant RA; Shane Pankratz V; Jacobsen SJ; Poland GA
    Vaccine; 2004 May; 22(15-16):1914-20. PubMed ID: 15121303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control over the postvaccinal measles immunity status using the indirect hemagglutination test with lyophilized diagnostic agents].
    Sokhin AA; Sliuar' LI; Smorodinova IP; Rodomskaia FS; Makarova EN
    Tr Inst Im Pastera; 1981; 56():121-3. PubMed ID: 7187542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-laboratory indices of children revaccinated against measles].
    Sorokina EA; Bystriakova LV; Sertakova ZL; Terekhova LE
    Tr Inst Im Pastera; 1985; 62():50-4. PubMed ID: 2954276
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY; Feng ZX; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine.
    St Sauver JL; Ovsyannikova IG; Jacobson RM; Jacobsen SJ; Vierkant RA; Schaid DJ; Pankratz VS; Green EM; Poland GA
    J Infect Dis; 2002 Jun; 185(11):1545-9. PubMed ID: 12023759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological study of postvaccinal measles immunity in the absence of a booster effect and in measles foci].
    Chudnaia LM; Fastovskaia BN; Shekhter AB; Orekhova GI; Dzhulaĭ AS
    Tr Inst Im Pastera; 1979; 53():71-5. PubMed ID: 262711
    [No Abstract]   [Full Text] [Related]  

  • 11. [The immune response of children with an iron deficiency to vaccination with a live measles vaccine].
    Kazakova LM; Makrushin IM; Tsvetova GV; Arsent'eva TN; Shabaldin AV
    Pediatriia; 1992; (7-9):36-7. PubMed ID: 1475138
    [No Abstract]   [Full Text] [Related]  

  • 12. Sidestepping maternal antibody: a lesson from measles virus vaccination.
    Kim D; Niewiesk S
    Expert Rev Clin Immunol; 2011 Sep; 7(5):557-9. PubMed ID: 21895466
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune response to measles vaccine in Peruvian children.
    Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
    Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF; Warburton MF
    Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nature of measles virus antibodies in systemic lupus erythematosus].
    Alekberova ZS; Karaseva IA
    Sov Med; 1980; (9):37-9. PubMed ID: 7423262
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vaccinal measles process in children during the manifestations of acute respiratory diseases].
    Sergeeva MV; Vorotyntseva NV; Titova NS
    Pediatriia; 1991; (10):57-61. PubMed ID: 1788003
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental measles. II. Infection and immunity in the rhesus macaque.
    Zhu YD; Heath J; Collins J; Greene T; Antipa L; Rota P; Bellini W; McChesney M
    Virology; 1997 Jun; 233(1):85-92. PubMed ID: 9229928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.